Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough? -- Ignore unavailable to you. Want to Upgrade?

To: Sparkle who wrote (41)	1/6/1998 11:34:00 PM
From: froland	Read Replies (1) \| Respond to of 226

I'm still looking at this one and kicking its tires. Don't know much about the fake diamond business or real diamond business but am trying to learn as much as I can. What has me most interested is the possibility of every jewler and pawn broker in the world needing the test equipment and NEEDING IT NOW!!! With only 5M shares outstanding, the effect on share price would be upward. In addition to a variety of other concerns/unknowns, I'm wondering if the test equipment will really be necessary. While conventional diamond probes fail to distinguish Moissanite from diamond. I've heard that the easiest way to identify it is by its double refraction. If you look through Moissanite from several different angles, you should see double images of facet lines or objects viewed through the stone. I don't know if this is an issue or not. Is this something that anyone with a 10X loupe can distinguish? I don't know and I'm trying to find out. froland.

To: Sparkle who wrote (41)	1/7/1998 10:26:00 AM
From: Leslie S. Feinberg	Read Replies (1) \| Respond to of 226

Sparkle; The IPO demand was so strong that the company doubled the number of shares offered. The short term effect was obviously to soften demand. The long term effect is that C3 and Cree Research have much more money to launch the product and set up large scale production facilities. The quality of the product is awsome! The next couple of months will bring significant appreciation to the share price and 12-18 months out the projections of some analysts is for significant profits. Not a bad lead time. Les